Össur hf. provided earnings guidance for the year 2022. The financial guidance for the full year 2022 is 4% to 6% organic sales growth.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.7 DKK | -2.38% | -1.37% | +4.55% |
04-23 | Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024 | |
04-23 | Embla Medical hf. Provides Earnings Guidance for the Year 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.55% | 1.79B | |
-10.44% | 21.34B | |
+6.12% | 19.13B | |
+7.15% | 14.46B | |
+13.18% | 10.63B | |
-10.48% | 2.2B | |
+22.33% | 638M | |
0.00% | 383M | |
+93.03% | 210M | |
+20.48% | 94.01M |
- Stock Market
- Equities
- EMBLA Stock
- News Embla Medical hf.
- Össur hf. Provides Earnings Guidance for the Year 2022